AddLife shares are traded on Nasdaq Stockholm, Nordic Large Cap

ADD Lonsamhet Vit

The share

Chart Bar

Financial reports and presentations



Corporate governance

  • AddLife Capital Markets Day Invitation

    AddLife invites investors, analysts, and financial media to it's hybrid Capital Markets Day on September 15, 2023.

    The Capital Markets Day aims to offer insights into AddLife's business model, portfolio companies, and strategic plans. Attendees will enjoy presentations, a Q&A session with our CEO Fredrik Dalborg and other key managers, plus a chance to interact with the management team.

    Read more and register
    AddLife Capital Markets Day
  • Demand is developing positively in all areas

    AddLife's subsidiaries have strong market positions in growing niches, which is clearly reflected in the company's net sales growth of 14% in the second quarter. Operating profit (EBITA) increased by 3% compared with the previous year, driven primarily by higher net sales growth, and the EBITA margin was 10.4%. In summary, I can conclude that AddLife's companies have strong market positions in well-chosen niches where the conditions for continued profitable growth are good.


    CEO comments Q2
    Fredrik Dalborg Q2 2023 3 (1)

Listen to our latest presentation


AddLife creates value

The laboratory and medical technology market is relatively insensitive to economic fluctuations. Growth tends to be stable and is mainly driven by population growth and an ageing population. These trends increase the demand for AddLife's healthcare and research products. Historically, the markets where we operate have grown at an annual rate of 2-4 percent.

AddLife’s subsidiaries are strongly cash generative, which gives financial opportunity for acquisitions and investments.

ADD Lonsamhet Vit

AddLife has substantial experience of acquisitions, identifying candidates and completing successful transactions.

ADD Ansvar Vit

AddLife’s subsidiaries have strong sales organisations with high technological expertise and long term customer relationships.

ADD Engagemang Vit

Target fulfilment 2022

Earnings growth



Contact us!

The investor pages contain all published financial information to facilitate investment decisions.

We are happy to assist you in understanding our business and financial results. Please do not hesitate to contact us if you would like more information, or if you have any suggestions for improving our service.


IR- and press contacts

Fredrik Dalborg (2)

Fredrik Dalborg


Christina Rubenhag

Christina Rubenhag